FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies ...Middle East

SILVER SPRING, Md., Nov. 20, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zokinvy (lonafarnib) capsules to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in...

Hence then, the article about fda approves first treatment for hutchinson gilford progeria syndrome and some progeroid laminopathies was published today ( Saturday 21/11/2020 - 02:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies )

Also on site :

• 'Love on the Spectrum' Star Hard Launches New Romance — And Fans Are Shocked by One Trait
• Who Won ‘Jeopardy’ Today? (July 6, 2026) Plus, the Final Jeopardy Answer
• Walmart’s Fan-Favorite Zero-Gravity Canopy Lounge Chair Is 50% Off and ‘Perfect for Bird Watching and Stargazing’